Caraco generates $40.4 million and $268 medical journal .2 million in third quarter, first nine months of Fiscal Year 2011 Caraco Pharmaceutical Laboratories, Ltd. Generated net product sales of $40.4 million and $268.2 million in the third quarter and first nine months of its Fiscal Year 2011, respectively, as compared to $52.0 million and $178.4 million, respectively, for the corresponding intervals of our earlier fiscal year ended December 31, 2009. Through the third one fourth and first nine weeks of Fiscal 2011, product sales of Caraco-owned products had been $5.7 million and $16.7 million, respectively, when compared with $3.3 million and $18.9 million, respectively, through the corresponding intervals of Fiscal 2010.

ed doctor

Kaiser Health Information, an editorially independent information service, is a scheduled plan of the Kaiser Family members Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.. Capitol Hill event highlights U.S. Advancements in malaria science, technology This post in Malaria No More’s ‘Malaria Policy Center’ blog reports on a two-part event held on Capitol Hill on Wednesday, April 25, World Malaria Day, titled, ‘U.S.’ Through the event, which presented the ‘co-chair of the Senate Working Group on Malaria and Congressional Caucus on Malaria and Neglected Tropical Illnesses as honorary hosts,’ ’20 universities, private businesses, and research organizations highlighted cutting-edge scientific and technological advancements in malaria that could save millions of lives around the world, guard U.S.